The new-fangled conceptual perspectives and advances in the world of salivary gland

R K Leema; Megha Kadani; S V Ravindra; J D Sunitha; Satya Narayana; Shanthi Priya

doi:10.53730/ijhs.v6nS2.5948

Authors

Leema R K Department of Oral Medicine and Radiology, MNR Dental College, Sangareddy
Megha Kadani Department of Oral Pathology and Microbiology, MNR Dental College, Sangareddy
Ravindra S V Department of Oral Medicine and Radiology, MNR Dental College, Sangareddy
Sunitha J D Department of Oral Pathology and Microbiology, MNR Dental College, Sangareddy
Satya Narayana Department of Public Health and Preventive Dentistry, MNR Dental College, Sangareddy
Shanthi Priya Department of Prosthodontics, MNR Dental College, Sangareddy

Keywords:

salivary gland, tubarial glands, autophagy, personalized therapy, stem cells

Abstract

Understanding the pathogenesis and being familiar with diagnostic and management methods is critical in order to provide effective oral health care for patients. The current knowledge of the pathogenesis of each cancer subtype has made it possible to classify and define salivary gland tumors better. Specific treatment regimens for salivary gland tumors can be developed by studying molecular biology. Using immunohistochemistry in conjunction with gene analysis using PCR, specific defects can be identified, which provides insight into the most promising therapies. Hypofunctional salivary glands may benefit from organ replacement regenerative therapy using human adult stem cells.

Downloads

Download data is not yet available.

References

Singh V, Reddy K. Discovery of new organs in human throat: The tubarial salivary glands. J Anat Soc India. 2021 Jan 1; 70(1):1-1.

Standring S. Gray’s Anatomy: The Anatomical Basis of Clinical Practice. 41st ed. London, UK: Elsevier; 2015.

Moore KL, Agur AM, Dalley AF. Clinically Oriented Anatomy. 7th ed. Philadelphia, Pennsylvania, United States: Lippincot Williams and Wilkins; 2018.

Klein Nulent TJW, Valstar MH, de Keizer B, Willems SM, Smit LA, Al-Mamgani A, Smeele LE, van Es RJJ, de Bree R, Vogel WV. Physiologic distribution of PSMA-ligand in salivary glands and seromucous glands of the head and neck on PET/CT. J Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 May; 125(5):478-486.

Tos M. Mucous glands in the developing human rhino pharynx. The Laryngoscope. 1977 Jun; 87(6):987-95.

Richardson MS. Non-neoplastic lesions of salivary glands. In: Thomson I, editor. Head and Neck Pathology. 2nd ed. Woodland Hills, CA: Elsevier Saunders; 2013 Jan 1: 228-243.

Berger G. Eustachian tube submucosal glands in normal and pathological temporal bones. J Laryngol Otol. 1993 Dec; 107(12):1099-105.

Suvvari TK, Arigapudi N. The tubarial glands: Discovered but not defined–A narrative review. J Radiat Cancer Res. 2020 Oct 1; 11(4):140.

Valstar MH, de Bakker BS, Steenbakkers RJ, de Jong KH, Smit LA, Nulent TJ, van Es RJ, Hofland I, de Keizer B, Jasperse B, Balm AJ. The tubarial salivary glands: A potential new organ at risk for radiotherapy. J Radiother Oncol. 2021 Jan 1; 154: 292-8.

Mentis AF, Chrousos GP. Tubarial salivary glands in Sjogren Syndrome: Are they just a potential missing link with no broader implications? J Front. Immunol. 2021; 1-3.

Sainudeen S, Sabujan A. Minor salivary glands and ‘Tubarial Glands’-Anatomy, physiology, and pathology relevant to radiology. J Radiol Clin Imaging. 2021; 4(1):1-4.

Koustas E, Sarantis P, Theodorakidou M, Karamouzis MV, Theocharis S. Autophagy and salivary gland cancer: A putative target for salivary gland tumors. J Tumour Biol. 2020 Dec; 42(12):1-12.

Jin S, White E. Role of autophagy in cancer: management of metabolic stress. J Autophagy. 2007 Jan 8; 3(1):28-31.

Kroemer G, Marino G, Levine B. Autophagy and the integrated stress response. J Mol cell. 2010 Oct 22; 40(2):280-93.

White E. Deconvoluting the context-dependent role for autophagy in cancer. J Nat Rev Cancer. 2012 June; 12(6): 401–410.

Kocaturk NM, Akkoc Y, Kig C, et al. Autophagy as a molecular target for cancer treatment. Eur J Pharm Sci. 2019 June 15; 134: 116–137.

Keller G, Steinmann D, Quaas A, Grünwald V, Janssen S, Hussein K. New concepts of personalized therapy in salivary gland carcinomas. J Oral Oncol. 2017 May 1; 68: 103-13.

Locati LD, Perrone F, Losa M, et al. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). J Oral Oncol. 2009 Nov 1; 45(11): 986–90.

Lemound J, Schenk M, Keller G, Stucki-Koch A, Witting S, Kreipe H, et al. Cytogenetic and immunohistochemical biomarker profiling of therapy relevant factors in salivary gland carcinomas. J Oral Pathol Med; 2016 Oct: 45(9).655-663.

Alotaibi AM, Alqarni MA, Alnobi A, Tarakji B. Human epidermal growth factor receptor 2 (HER2/neu) in salivary gland carcinomas: a review of the literature. J Clin Diagn Res 2015 Feb; 9(2): ZE04–8.

Cros J, Sbidian E, Hans S, et al. Expression and mutational status of treatment relevant targets and key oncogenes in 123 malignant salivary gland tumors. J Ann Oncol. 2013 Oct 1; 24(10): 2624–9.

Grünewald I, Vollbrecht C, Meinrath J, et al. Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity. J Oncotarget. 2015 Jul 20; 6(20): 18224–37.

Weinreb I, Piscuoglio S, Martelotto LG, Waggott D, Ng CK, Perez-Ordonez B, et al. Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands. J Nat Genet. 2014 Nov; 46(11):1166–9.

Ho AS, Kannan K, Roy DM, Morris LG, Ganly I, Katabi N, et al. The mutational landscape of adenoid cystic carcinoma. J Nat Genet. 2013 Jul; 45(7):791–8.

Kang H, Tan M, Bishop JA, Jones S, Sausen M, Ha PK, Agrawal N. Whole-exome sequencing of salivary gland mucoepidermoid carcinoma. J Clin Cancer Res. 2017 Jan 1; 23(1):283-8.

Borges S, Döppler H, Perez EA, Andorfer CA, Sun Z, Anastasiadis PZ, et al. Pharmacologic reversion of epigenetic silencing of the PRKD1 promoter blocks breast tumor cell invasion and metastasis. J Breast Cancer Res.2013 Apr; 15 (2): R66.

Meyer MT, Watermann C, Dreyer T, Ergün S, Karnati S. 2021 Update on Diagnostic Markers and Translocation in Salivary Gland Tumors. Int. J. Mol. Sci. 2021 Jan; 22(13):6771.

Curran, A.E.; Allen, C.M.; Beck, F.M.; Damm, D.D.; Murrah, V.A. Distinctive Pattern of Glial Fibrillary Acidic Protein Immunoreactivity Useful in Distinguishing Fragmented Pleomorphic Adenoma, Canalicular Adenoma and Polymorphous Low-Grade Adenocarcinoma of Minor Salivary Glands. J Head Neck Pathol. 2007 Sep; 1(1). 27–32.

Schneider, S.; Kloimstein, P.; Pammer, J.; Brannath, W.; Grasl, M.C.; Erovic, B.M. New Diagnostic Markers in Salivary Gland Tumors. Eur. Arch. Otorhinolaryngol. 2014 Jul, 271(1); 1999–2007.

Zhu, S.; Schuerch, C.; Hunt, J. Review and Updates of Immunohistochemistry in Selected Salivary Gland and Head and Neck Tumors. J Arch. Pathol. Lab. Med. 2015 Jan; 139(1). 55–66.

McCord C, Weinreb I, Perez-Ordonez B. Progress in salivary gland pathology: new entities and selected molecular features. J Diagn Histopathol. 2012 June 1; 18(6): 253–260.

Skalova A, Vanecek T, Simpson RHW, et al. Molecular advances in salivary gland pathology and their practical application. J Diagn Histopathol. 2012 Sep 1; 18(1):388–396.

Weinreb I. Translocation-associated salivary gland tumors: a review and update. J Adv Anat Pathol. 2013 Nov 1; 20 (6):367–376.

Simpson RHW, Skálová A, Di Palma S, et al. Recent advances in the diagnostic pathology of salivary glands. J Virchows Archiv. 2014 Oct; 465(4):371–384.

Garcia JJ, Oloviera AM. Fusion transcripts that characterize malignancies of salivary gland origin. J Pathol Case Reviews. 2015 Jan 1; 20(1):22–26.

Skalova A, Michal M, Simpson RH. Newly described salivary gland tumors. Modern Pathology. 2017 Jan; 30(1): 27-43.

Smith BC, Ellis GL, Slater LJ, et al. Sclerosing polycystic adenosis of major salivary glands: a clinic-pathologic analysis of nine cases. Am J Surg Pathol. 1996 Feb 1; 20(2): 161-170.

Skalova A, Michal M, Simpson RH, et al. Sclerosing polycystic adenosis of the parotid gland with dysplasia and ductal carcinoma in situ. Report of three cases with the immunohistochemical and ultrastructural examination. J Virchows Archiv. 2002 Jan; 440(1): 29–35.

Imamura Y, Morishita T, Kawakami M, et al. Sclerosing polycystic adenosis of the left parotid gland: report of a case with fine-needle aspiration cytology. J Acta Cytol. 2004 Jul 1; 48(4): 569–573.

Gnepp DR, Wang LJ, Brandwein-Gensler M, et al. Sclerosing polycystic adenosis of the salivary gland. Am J Surg Pathol. 2006 Feb 1; 30(2):154-164.

Skálová A, Gnepp DR, Simpson RH, et al. Clonal nature of sclerosing polycystic adenosis of salivary glands demonstrated by using the polymorphism of the human androgen receptor (HUMARA) locus as a marker. Am J Surg Pathol. 2006 Aug 1; 30(8): 939-944.

Kloppenborg RP, Sepmeijer JW, Sie-Go DM, et al. Sclerosing polycystic adenosis: a case report. B-Ent. 2006 Jan 1; 2: 189-192.

Bharadwaj G, Nawroz I, O’Regan B. Sclerosing polycystic adenosis of the parotid gland. Br J Oral Maxillofac Surg. 2007 Jan 1; 45(1): 74-76.

Fulciniti F, Losito NS, Ionna F, et al. Sclerosing polycystic adenosis of the parotid gland: report of one case diagnosed by fine-needle cytology with in situ malignant transformations. J Diagn Cytopathol. 2010 May; 38(5): 368-373.

Gurgel CA, Freitas VS, Ramos EA, et al. Sclerosing polycystic adenosis of the minor salivary gland: case report. Braz J Otorhinolaryngol. 2010 April; 76(2): 272.

Perottino F, Barnoud R, Ambrun A, et al. Sclerosing polycystic adenosis of the parotid gland: diagnosis and management. Eur Ann Otorhinolaryngol Head Neck Dis. 2010 Mar 24; 127(1): 20–22.

Petersson F, Tan PH, Hwang JS. Sclerosing polycystic adenosis of the parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking invasive carcinoma. Head Neck Pathol. 2011 Jun; 5(2): 188-192.

Michal M, Skálová A, Simpson RHW, et al. Cribriform adenocarcinoma of the tongue: a hitherto unrecognized type of adenocarcinoma characteristically occurring in the tongue. Histopathology.1999 Dec 1; 35(6): 495–501.

Skalova A, Sima R, Kaspirkova-Nemcova J, et al. Cribriform adenocarcinoma of minor salivary gland origin principally affecting the tongue: characterization of a new entity. Am J Surg Pathol. 2011 Aug 1; 35(8): 1168- 1176.

Luna MA, Wenig BM. Polymorphous low-grade adenocarcinoma. In: Barnes EL, Eveson JW, Reichart P, et al. (eds). World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. IARC Press: Lyon, France, 2005, pp 223–224.

Scott, J. Quantitative age changes in the histological structure of human submandibular salivary glands. Arch. Oral Biol. 1977 Jan 1; 22(3): 221–227.

Ekström, J.; Khosravani, N.; Castagnola, M.; Messana, I. Saliva and the control of its secretion. In Dysphagia. Medical Radiology; Ekberg, O., Ed.; Springer: Cham, Switzerland, 2017.

Toan NK, Ahn SG. Aging-Related Metabolic Dysfunction in the Salivary Gland: A Review of the Literature. Int J Mol Sci. 2021 Jan; 22 (11):5835.

Leehan, K.M.; Pezant, N.P.; Rasmussen, A.; Grundahl, K.; Moore, J.S.; Radfar, L.; Lewis, D.M.; Stone, D.U.; Lessard, C.J.; Rhodus, N.L.; et al. Minor salivary gland fibrosis in sjögren’s syndrome is elevated, associated with focus score and not solely a consequence of aging. Clin. Exp. Rheumatol. 2018, 36 (Suppl. 112), 80–88.

Pedersen, A.M.L.; Sorensen, C.E.; Proctor, G.B.; Carpenter, G.H.; Ekström, J. Salivary secretion in health and disease. J. Oral Rehabil. 2018 Sep; 45(9): 730–746.

Lasisi, T.J.; Shittu, S.T.; Oguntokun, M.M.; Tiamiyu, N.A. Aging affects morphology but not stimulated secretion of saliva in rats. Ann. Ib. Postgrad. Med. 2014; 12(2): 109–114.

Zhang X, Yun JS, Han D, Yook JI, Kim HS, Cho ES. TGF-β Pathway in Salivary Gland Fibrosis. Int J Mol Sci. 2020 Jan; 21(23):9138.

Riley, P.; Glenny, A.M.; Hua, F.; Worthington, H.V. Pharmacological interventions for preventing dry mouth and salivary gland dysfunction following radiotherapy. Cochrane Database Syst. Rev. 2017, 7, CD012744.

Sulistiyani E, Brimson JM, Chansaenroj A, Sariya L, Urkasemsin G, Oonsiri S, Tencomnao T, Vacharaksa A, Chaisuparat R, Ferreira JN. Epigallocatechin-3-Gallate Protects Pro-Acinar Epithelia Against Salivary Gland Radiation Injury. Int J Mol Sci. 2021 Jan; 22(6):3162.

Usami Y, Hirose K, Okumura M, Toyosawa S, Sakai T. Brief communication: Immunohistochemical detection of ACE2 in the human salivary gland. Oral Sci Int. 2021 May; 18(2):1–4.

Czumbel LM, Kiss S, Farkas N, Mandel I, Hegyi A, Nagy Á, Lohinai Z, Szakács Z, Hegyi P, Steward MC, Varga G. Saliva as a candidate for COVID-19 diagnostic testing: a meta-analysis. Front Med. 2020 Aug 4; 7: 465.

Xu J, Li Y, Gan F, Du Y, Yao Y. Salivary glands: potential reservoirs for COVID-19 asymptomatic infection. J Dent Res. 2020 Jul; 99(8):989.

Dave PK, Rojas-Cessa R, Dong Z, Umpaichitra V. Survey of saliva components and virus sensors for prevention of COVID-19 and infectious diseases. Biosensors. 2021 Jan; 11(1):14.

Rocchi C, Barazzuol L, Coppes RP. The evolving definition of salivary gland stem cells. Npj Regen Med. 2021 Feb 1; 6 (1):1-8.

Nanduri LS, Maimets M, Pringle SA, Van Der Zwaag M, Van Os RP, Coppes RP. Regeneration of irradiated salivary glands with stem cell marker expressing cells. Radiother Oncol. 2011 Jun 1; 99(3):367-72.